#MASLD Archives - MediaMedic

AASLD Exclusive Interview with Dr. Vincent Wai-Sun Wong: Challenges and Frontiers in Managing MASLD in Asia

By Lisa Cui 2024.12.26

The prevalence of metabolic dysfunction-associated steatotic liver disease (MASLD) continues to rise globally, driven by the increasing rates of obesity and metabolic syndrome. Epidemiological studies indicate that by 2019, the…

AASLD Expert Interview丨Dr. Lungen Lu Shares New Advances in MASLD Research

By Peng Longmei 2024.12.24

From November 15 to 19, 2024, the Annual Meeting of the American Association for the Study of Liver Diseases (AASLD 2024) was held in San Diego, USA. Hepatology Digest invited…

AASLD 2024 | Dr. Hong Tang’s Team Advances HBV, MASLD, Liver Fibrosis, HCC, and ACLF Research

By Mourabit Halima 2024.12.24

Recently, the 75th Annual Meeting of the American Association for the Study of Liver Diseases (AASLD) was held in San Diego, USA. At the event, a team led by Dr.…

AASLD 2024丨Artificial Intelligence Enhancing Early Diagnosis of Metabolic Associated Steatotic Liver Disease

By Mourabit Halima 2024.11.21

At the 2024 Annual Meeting of the American Association for the Study of Liver Diseases (AASLD) held on November 15 in San Diego, California, a groundbreaking study highlighted the transformative…

Hepatology | Association Between Metabolic-Associated Fatty Liver Disease and Subclinical Hypothyroidism in Adolescents

By Lisa Cui 2024.10.17

Editor's Note: A recent study led by Dr. Vidhu V. Thaker from Columbia University Medical Center has revealed a significant association between subclinical hypothyroidism and metabolic-associated steatotic liver disease (MASLD)…

JHEP | MASLD Without Cirrhosis Still Poses High Liver Cancer Risk, Presenting Challenges for Clinical Management

By El Bachir MOURABIT 2024.09.10

Editor's Note: Metabolic-associated steatotic liver disease (MASLD) has become the fastest-growing cause of hepatocellular carcinoma (HCC). A recent multicenter clinical study led by Dr. Carole Vitellius from Angers University Hospital,…

Hepatology丨Chinese Researchers Confirm that the EAT-Lancet Diet Significantly Reduces the Risk of Metabolic-Associated Fatty Liver Disease

By Mourabit Halima 2024.09.02

Editor's Note With the global rise in obesity, diabetes, and metabolic syndrome, the prevalence of metabolic-associated fatty liver disease (MASLD) is also increasing. Statistics show that MASLD has become one…

AASLD Hot Updates on MASLD from the 2023 Annual Meeting

By Kenzy Nour 2024.01.16

Editor's Note: On November 7, 2023, at 12:30 PM local time in Boston, the American Association for the Study of Liver Diseases (AASLD) held its sole pre-conference press briefing on…